MarginsXMarginsX
Home › Data Desk › Going-concern doubt appears in DiaMedica Therapeutics Inc.'s 10-Q

MarginsX Data Desk · Going-concern doubt · At-the-market offering

Going-concern doubt appears in DiaMedica Therapeutics Inc.'s 10-Q

In its 10-Q, filed Nov 12, 2026, DiaMedica Therapeutics Inc. (DMAC) disclosed substantial doubt that it can carry on as a going concern. (SEC EDGAR, 10-Q, Nov 12, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 12, 2026.

Line chart of DiaMedica Therapeutics Inc. (DMAC) daily closes from Jul 6, 2026 to Nov 12, 2026, with the going-concern filing on Nov 12, 2026 marked.

The filing reads: “These factors, among others, raise substantial doubt about our ability to continue operations as a going concern which is not alleviated.” (SEC EDGAR, 10-Q, Nov 12, 2026)

Why we call it new

Its previous periodic report, the 10-Q filed Aug 10, 2026, did not match EDGAR full-text search for going-concern language when we last ran it on Nov 14, 2026. (SEC EDGAR, 10-Q, Aug 10, 2026)

Cash and dilution

It reported cash of $6.8M as of Sep 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

At its recent quarterly burn rate that cash lasts about 2.4 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

Its share count rose 3.6% over the past year. (Company health, computed by us from SEC filings and XBRL, Nov 9, 2026)

The stock

The Nasdaq screener puts its market value at $474.3M. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/DMAC)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameDiaMedica Therapeutics Inc.Source2026-11-13
Form10-QSource2026-11-12
FiledNov 12, 2026Source2026-11-12
WhoDiaMedica Therapeutics Inc. (DMAC)Source2026-11-13
SymbolDMACSource2026-11-13
SentenceThese factors, among others, raise substantial doubt about oSource2026-11-12
Prev form10-QSource2026-08-10
Prev filedAug 10, 2026Source2026-08-10
Fts checkedNov 14, 2026Source2026-11-14
Cash6,800,000 USDSource2026-09-30
Cash dateSep 30, 2026Source2026-09-30
Runway2.4 monthsSource2026-09-30
Dilution 1y3.6 %Source2026-11-09
Cap474,286,196 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS